Literature DB >> 17214350

Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum.

A Lukic1, C Canzio, A Patella, M Giovagnoli, P Cipriani, A Frega, M Moscarini.   

Abstract

OBJECTIVE: To evaluate the existence of an association between cervicovaginal infections and precancerous lesions of the uterine cervix, through determination of prevalent cervicovaginal micro-organisms, alone and in association with human papillomavirus (HPV), in patients with abnormal and normal vaginal cytology. PATIENTS AND METHODS: Patients with abnormal vaginal cytology were divided into three study groups according to cytological findings: ASC-US, L-SIL and H-SIL. All patients underwent colposcopic examination and exoendocervical and vaginal sampling for microbiological and molecular analysis for detection of HPV-DNA, Ureaplasma urealyticum, Chlamydia trachomatis, Trichomonas vaginalis, mycetes and common bacteria. Results were compared with the patient group asymptomatic for cervicovaginal inflammation with negative vaginal cytology and colposcopy.
RESULTS: A high association between Ureaplasma urealyticum infection and the grade of cytological cervical lesion (27% for ASC-US, 35% for L-SIL and 45% for H-SIL) was found. Furthermore, 19% of the control group samplings were positive for Ureaplasma urealyticum, significantly less than that observed in the positive cytology groups. An interesting association of HPV with Ureaplasma urealyticum in patients with H-SIL vaginal cytology (83%), much higher than that observed in patients with slightly abnormal or normal vaginal cytology (56% for ASC-US, 49% for L-SIL, 40% for normal cytology) was also identified. In contrast, the association between Papillomavirus and multiple microorganisms seemed to decrease with the level of cellular dysplasia in 30% of controls, 33% of ASC-US, 32% of L-SIL and 17% of H-SIL.
CONCLUSION: The presence of a high Ureaplasma urealyticum level seems to be a cofactor of HPV infection, a necessary cause of precancerous lesions of the uterine cervix. The presence of Ureaplasma urealyticum may play a role both in initiating viral cellular anomalies and in viral persistence. It can be hypothesized that these initial processes are helped by a state of cervical inflammation, also supported by multiple microorganisms. It would, thus, be suggested for all patients who present with an abnormal PAP test to undergo a cervicovaginal microbiological examination to detect potentially pathogenic microbes for correct diagnosis and treatment, as well as a more complete follow-up of cervical cytological lesions.

Entities:  

Mesh:

Year:  2006        PMID: 17214350

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

1.  Molecular Detection of Sexually Transmitted Infections in Women with and without Human Papillomaviruses Infection Who Referred to Tehran West Hospitals in Iran.

Authors:  Seyed Mojtaba Mortazavi; Amin Tarinjoo; Sepideh Dastani; Majid Niyazpour; Samira Dahaghin; Reza Mirnejad
Journal:  Rep Biochem Mol Biol       Date:  2021-10

2.  Human Papillomaviruses and genital co-infections in gynaecological outpatients.

Authors:  Rosita Verteramo; Alessandra Pierangeli; Emanuela Mancini; Ettore Calzolari; Mauro Bucci; John Osborn; Rosa Nicosia; Fernanda Chiarini; Guido Antonelli; Anna Marta Degener
Journal:  BMC Infect Dis       Date:  2009-02-12       Impact factor: 3.090

3.  Investigation of the association between ten pathogens causing sexually transmitted diseases and high-risk human papilloma virus infection in Shanghai.

Authors:  Li Xie; Qian Li; Xiangrong Dong; Qi Kong; Yuping Duan; Xiong Chen; Xiaoqiang Li; Mao Hong; Tao Liu
Journal:  Mol Clin Oncol       Date:  2021-05-09

4.  High-risk human papillomavirus infection is associated with premature rupture of membranes.

Authors:  GeumJoon Cho; Kyung-Jin Min; Hye-Ri Hong; SuhngWook Kim; Jin-Hwa Hong; Jae-Kwan Lee; Min-Jeong Oh; HaiJoong Kim
Journal:  BMC Pregnancy Childbirth       Date:  2013-09-06       Impact factor: 3.007

5.  Inflammation on the cervical papanicolaou smear: evidence for infection in asymptomatic women?

Authors:  Stavroula Baka; Ioanna Tsirmpa; Anthia Chasiakou; Iliana Tsouma; Ekaterina Politi; Vassiliki Gennimata; Evangelia Kouskouni
Journal:  Infect Dis Obstet Gynecol       Date:  2013-09-24

6.  Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients.

Authors:  Hye Sun Kim; Tae Jin Kim; In Ho Lee; Sung Ran Hong
Journal:  J Gynecol Oncol       Date:  2016-05-16       Impact factor: 4.401

7.  Occurrence of Ureaplasma parvum and Ureaplasma urealyticum in women with cervical dysplasia in Katowice, Poland.

Authors:  Alicja M Ekiel; Daniela A Friedek; Małgorzata K Romanik; Jarosław Jóźwiak; Gayane Martirosian
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

8.  Cervical cytopathological findings in Korean women with Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum infections.

Authors:  Yuri Choi; Jaesook Roh
Journal:  ScientificWorldJournal       Date:  2014-01-08

9.  Co-infection of sexually transmitted pathogens and Human Papillomavirus in cervical samples of women of Brazil.

Authors:  Aline Teixeira Amorim; Lucas Miranda Marques; Guilherme Barreto Campos; Tássia Neves Lobão; Vanesca de Souza Lino; Ricardo Cesar Cintra; Maria Antonieta Andreoli; Luisa Lina Villa; Enrique Boccardo; Antonio Carlos Ricardo Braga Junior; Rossana Verónica Mendoza López; Djanilson Barbosa Dos Santos; Gerson Maciel de Souza; Carla Cristina Romano; Jorge Timenetsky
Journal:  BMC Infect Dis       Date:  2017-12-15       Impact factor: 3.090

10.  Co-infection Of Ureaplasma urealyticum And Human Papilloma Virus In Asymptomatic Sexually Active Individuals.

Authors:  Sang Il Kim; Joo Hee Yoon; Dong Choon Park; Dong Sup Lee; Seung Ju Lee; Hyun Sop Choe; Jin Hwi Kim; Tae Chul Park; Sung Jong Lee
Journal:  Int J Med Sci       Date:  2018-06-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.